Informations générales (source: ClinicalTrials.gov)
National Cohort of Patients With Cowden's Disease and With a Constitutional Alteration of the PTEN Gene for the Prospective Assessment of the Risk of Cancer. (COCO)
Observational
Institut Bergonié (Voir sur ClinicalTrials)
février 2023
janvier 2048
19 novembre 2024
This is a multicentric, observational, retrospective and prospective study, aiming to
estimate the risk of cancer occurrence in subjects carrying a PTEN mutation, based on the
constitution of a national cohort.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT CURIE | 04/12/2024 12:44:28 | Contact (sur clinicalTrials) | |||
| CLCC RENE HUGUENIN INSTITUT CURIE | 04/12/2024 12:44:10 | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Institut Bergonié, Comprehensive Cancer Center - Bordeaux - France | Contact (sur clinicalTrials) | ||||
Critères
Tous
Inclusion Criteria:
1. Male or female.
2. Adult or child without age limit.
3. Carrier of a constitutional or mosaic alteration of the PTEN gene established and/or
confirmed by the Institut Bergonié's genetics laboratory, following a request for
molecular diagnosis made between 1997 and 2027.
4. Participant informed of his genetic diagnosis.
5. Participant informed and not having expressed non-opposition to participate in the
research.
6. Participant affiliated to a French social security system in accordance with French
law on research involving the human person.
1. Male or female.
2. Adult or child without age limit.
3. Carrier of a constitutional or mosaic alteration of the PTEN gene established and/or
confirmed by the Institut Bergonié's genetics laboratory, following a request for
molecular diagnosis made between 1997 and 2027.
4. Participant informed of his genetic diagnosis.
5. Participant informed and not having expressed non-opposition to participate in the
research.
6. Participant affiliated to a French social security system in accordance with French
law on research involving the human person.
1. Participant under guardianship or curatorship. Exception: a participant with autism
may be included in the study.
2. Persons deprived of their liberty by a judicial or administrative decision.
3. Persons under psychiatric care, persons admitted to a health or social establishment
for purposes other than research; Exception: a participant with autism may be
included in the study.